New heart valve under 10-Year watch: will it last?

NCT ID NCT06953206

Recruiting now Disease control Sponsor: Institut für Pharmakologie und Präventive Medizin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This registry will follow 500 adults with severe aortic stenosis who receive a SAPIEN 3 Ultra Resilia heart valve through a minimally invasive procedure. Researchers will track how well the valve works and how safe it is over 10 years. The goal is to see if this newer valve design holds up better over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SAPIEN 3 Ultra Resilia heart valve
What this could lead to: If successful, this registry could confirm that the SAPIEN 3 Ultra Resilia valve is durable and safe over 10 years, helping doctors choose the best valve for patients with aortic stenosis.
What could go wrong: This is an observational registry, not a controlled trial, so results may not prove the valve is better than others. Valve failure or complications could still occur over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve insufficiency aortic valve stenosis heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC INSUFFICIENCY AORTIC STENOSIS DEGENERATIVE VALVE DISEASE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)

Contacts and locations

Locations

Heart and Diabetes Center North Rhine-Westphalia
RECRUITING

Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.